down arrow

Glenmark Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE935A01035
  • NSEID: GLENMARK
  • BSEID: 532296
INR
1,370.20
-6.15 (-0.45%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 4.46 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

1,360.201,431.00

52 Week

985.601,830.05
Valuation
Technical
Day's Volume

CASH

4.46 lacs (10.24%) Volume

Shareholding (Dec 2024)

FII

23.51%

Held by 348 FIIs

DII

13.89%

Held by 35 DIIs

Promoter

46.65%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 4.85% and Operating profit at 7.80% over the last 5 years

 
2

Stock is technically in a Mildly Bearish range

3

With ROE of -5.9, it has a Very Expensive valuation with a 4.6 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 38,665 Cr (Large Cap)

stock-summary
P/E

158.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.18%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

-5.86%

stock-summary
Price to Book

4.60

Revenue and Profits (1 Year):
Net Sales:
3,388 Cr
(Quarterly Results - Dec 2024)
Net Profit:
348 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.18%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-23.68%
0%
-23.68%
1 Year
31.41%
0.24%
31.65%
2 Years
182.37%
0.88%
183.25%
3 Years
186.59%
1.92%
188.51%
4 Years
158.72%
1.66%
160.38%
5 Years
453.17%
3.55%
456.72%

Latest dividend: 2.5 per share ex-dividend date: Sep-13-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
4.85%
EBIT Growth (5y)
7.80%
EBIT to Interest (avg)
4.54
Debt to EBITDA (avg)
1.88
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.01
Tax Ratio
100.00%
Dividend Payout Ratio
-4.70%
Pledged Shares
0
Institutional Holding
37.39%
ROCE (avg)
13.43%
ROE (avg)
8.62%
Valuation key factors
Factor
Value
P/E Ratio
158
Industry P/E
33
Price to Book Value
4.60
EV to EBIT
21.73
EV to EBITDA
16.88
EV to Capital Employed
4.65
EV to Sales
2.95
PEG Ratio
NA
Dividend Yield
0.18%
ROCE (Latest)
11.39%
ROE (Latest)
-5.86%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Bullish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 25 Schemes (12.12%)

FIIs

Held by 348 FIIs (23.51%)

Promoter with highest holding

Saldanha Family Trust (45.45%)

Highest Public shareholder

Mirae Asset Large & Midcap Fund (3.55%)

Individual Investors Holdings

12.65%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -1.35% vs 5.84% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -1.76% vs 4.10% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,387.55",
          "val2": "3,433.80",
          "chgp": "-1.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "600.23",
          "val2": "601.92",
          "chgp": "-0.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "52.29",
          "val2": "48.48",
          "chgp": "7.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "347.96",
          "val2": "354.21",
          "chgp": "-1.76%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.18%",
          "val2": "17.70%",
          "chgp": "0.48%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 6.96% vs 13.88% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 921.44% vs -84.99% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,677.98",
          "val2": "6,243.45",
          "chgp": "6.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,190.13",
          "val2": "899.64",
          "chgp": "32.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "88.06",
          "val2": "233.07",
          "chgp": "-62.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-377.45",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "694.48",
          "val2": "67.99",
          "chgp": "921.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.97%",
          "val2": "14.61%",
          "chgp": "3.36%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 15.03% vs 1.95% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 467.86% vs -139.06% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,065.53",
          "val2": "8,750.15",
          "chgp": "15.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,790.36",
          "val2": "690.99",
          "chgp": "159.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "140.35",
          "val2": "367.41",
          "chgp": "-61.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-335.40",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,042.44",
          "val2": "-283.38",
          "chgp": "467.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.79%",
          "val2": "7.90%",
          "chgp": "9.89%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -9.06% vs 5.57% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -605.19% vs -68.44% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11,813.10",
          "val2": "12,990.11",
          "chgp": "-9.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,195.34",
          "val2": "2,278.37",
          "chgp": "-47.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "515.97",
          "val2": "349.58",
          "chgp": "47.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-503.63",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-1,501.67",
          "val2": "297.25",
          "chgp": "-605.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.27%",
          "val2": "17.90%",
          "chgp": "-7.63%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
3,387.55
3,433.80
-1.35%
Operating Profit (PBDIT) excl Other Income
600.23
601.92
-0.28%
Interest
52.29
48.48
7.86%
Exceptional Items
0.00
0.00
Consolidate Net Profit
347.96
354.21
-1.76%
Operating Profit Margin (Excl OI)
18.18%
17.70%
0.48%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -1.35% vs 5.84% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -1.76% vs 4.10% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
6,677.98
6,243.45
6.96%
Operating Profit (PBDIT) excl Other Income
1,190.13
899.64
32.29%
Interest
88.06
233.07
-62.22%
Exceptional Items
0.00
-377.45
100.00%
Consolidate Net Profit
694.48
67.99
921.44%
Operating Profit Margin (Excl OI)
17.97%
14.61%
3.36%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 6.96% vs 13.88% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 921.44% vs -84.99% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
10,065.53
8,750.15
15.03%
Operating Profit (PBDIT) excl Other Income
1,790.36
690.99
159.10%
Interest
140.35
367.41
-61.80%
Exceptional Items
0.00
-335.40
100.00%
Consolidate Net Profit
1,042.44
-283.38
467.86%
Operating Profit Margin (Excl OI)
17.79%
7.90%
9.89%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 15.03% vs 1.95% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is 467.86% vs -139.06% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
11,813.10
12,990.11
-9.06%
Operating Profit (PBDIT) excl Other Income
1,195.34
2,278.37
-47.54%
Interest
515.97
349.58
47.60%
Exceptional Items
-503.63
0.00
Consolidate Net Profit
-1,501.67
297.25
-605.19%
Operating Profit Margin (Excl OI)
10.27%
17.90%
-7.63%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -9.06% vs 5.57% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is -605.19% vs -68.44% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Glenmark Pharmaceuticals Ltd. stock-summary
stock-summary
Glenmark Pharmaceuticals Ltd.
Large Cap
Pharmaceuticals & Drugs
Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets.
Company Coordinates stock-summary
Company Details
B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road Mumbai Maharashtra : 400026
stock-summary
Tel: 91-22-40189999
stock-summary
http://www.glenmarkpharma.com
stock-summary
complianceofficer@glenmarkpharma.co
Registrar Details
Karvy Computershare Pvt Ltd, Plot No 17-24 , Near Image Hospital,, Reliance Cybervilae,Vithalrao Nagar,, Madhapur, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."